Literature DB >> 21531893

Donor CD8 T cells and IFN-gamma are critical for sex-based differences in donor CD4 T cell engraftment and lupus-like phenotype in short-term chronic graft-versus-host disease mice.

Anthony D Foster1, Kateryna Soloviova, Irina Puliaeva, Maksym Puliaiev, Roman Puliaev, Fred Finkelman, Charles S Via.   

Abstract

The transfer of unfractionated DBA/2J (DBA) splenocytes into B6D2F(1) (DBA → F(1)) mice results in greater donor CD4 T cell engraftment in females at day 14 that persists long-term and mediates greater female lupus-like renal disease. Although donor CD8 T cells have no demonstrated role in lupus pathogenesis in this model, we recently observed that depletion of donor CD8 T cells prior to transfer eliminates sex-based differences in renal disease long-term. In this study, we demonstrate that greater day 14 female donor CD4 engraftment is also critically dependent on donor CD8 T cells. Male DBA → F(1) mice exhibit stronger CD8-dependent day 8-10 graft-versus-host (GVH) and counter-regulatory host-versus-graft (HVG) responses, followed by stronger homeostatic contraction (days 10-12). The weaker day 10-12 GVH and HVG in females are followed by persistent donor T cell activation and increasing proliferation, expansion, and cytokine production from days 12 to 14. Lastly, greater female day 14 donor T cell engraftment, activation, and cytokine production were lost with in vivo IFN-γ neutralization from days 6 to 14. We conclude the following: 1) donor CD8 T cells enhance day 10 proliferation of donor CD4 T cells in both sexes; and 2) a weaker GVH/HVG in females allows prolonged survival of donor CD4 and CD8 T cells, allowing persistent activation. These results support the novel conclusion that sex-based differences in suboptimal donor CD8 CTL activation are critical for shaping sex-based differences in donor CD4 T cell engraftment at 2 wk and lupus-like disease long-term.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21531893      PMCID: PMC3215299          DOI: 10.4049/jimmunol.1001074

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  30 in total

1.  In vivo neutralization of TNF-alpha promotes humoral autoimmunity by preventing the induction of CTL.

Authors:  C S Via; A Shustov; V Rus; T Lang; P Nguyen; F D Finkelman
Journal:  J Immunol       Date:  2001-12-15       Impact factor: 5.422

Review 2.  The chronic graft-versus-host model of systemic autoimmunity.

Authors:  Robert Eisenberg
Journal:  Curr Dir Autoimmun       Date:  2003

3.  TNF enhances CD4+ T cell alloproliferation, IFN-gamma responses, and intestinal graft-versus-host disease by IL-12-independent mechanisms.

Authors:  Geri R Brown; Edward L Lee; Dwain L Thiele
Journal:  J Immunol       Date:  2003-05-15       Impact factor: 5.422

4.  Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation.

Authors:  Michael R Betts; Jason M Brenchley; David A Price; Stephen C De Rosa; Daniel C Douek; Mario Roederer; Richard A Koup
Journal:  J Immunol Methods       Date:  2003-10-01       Impact factor: 2.303

5.  Role of perforin in controlling B-cell hyperactivity and humoral autoimmunity.

Authors:  A Shustov; I Luzina; P Nguyen; J C Papadimitriou; B Handwerger; K B Elkon; C S Via
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

6.  Differential requirement for IFN-gamma in CTL maturation in acute murine graft-versus-host disease.

Authors:  Roman Puliaev; Phuong Nguyen; Fred D Finkelman; Charles S Via
Journal:  J Immunol       Date:  2004-07-15       Impact factor: 5.422

Review 7.  Interleukin-21: basic biology and implications for cancer and autoimmunity.

Authors:  Rosanne Spolski; Warren J Leonard
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

8.  Increased severity of murine lupus in female mice is due to enhanced expansion of pathogenic T cells.

Authors:  Thomas J Lang; Phuong Nguyen; John C Papadimitriou; Charles S Via
Journal:  J Immunol       Date:  2003-12-01       Impact factor: 5.422

9.  Attempts at standardization of lupus-like graft-vs-host disease: inadvertent repopulation by DBA/2 spleen cells of H-2-different nonirradiated F1 mice.

Authors:  F M Van Rappard-Van Der Veen; T Radaszkiewicz; L Terraneo; E Gleichmann
Journal:  J Immunol       Date:  1983-06       Impact factor: 5.422

10.  Diseases caused by reactions of T lymphocytes towards incompatible structures of the major histocompatibility complex. VI. Autoantibodies characteristic of systemic lupus erythematosus induced by abnormal T-B cell cooperation across I-E.

Authors:  F M van Rappard-van der Veen; A G Rolink; E Gleichmann
Journal:  J Exp Med       Date:  1982-05-01       Impact factor: 14.307

View more
  9 in total

1.  In vivo IL-4 prevents allo-antigen driven CD8+ CTL development.

Authors:  Charles S Via; Kateryna Soloviova; Maksym Puliaiev; Roman Puliav; Irina Puliaeva; Suzanne C Morris; Fred D Finkelman
Journal:  Clin Immunol       Date:  2017-03-27       Impact factor: 3.969

2.  Both perforin and FasL are required for optimal CD8 T cell control of autoreactive B cells and autoantibody production in parent-into-F1 lupus mice.

Authors:  Kateryna Soloviova; Maksym Puliaiev; Roman Puliaev; Irina Puliaeva; Charles S Via
Journal:  Clin Immunol       Date:  2018-06-22       Impact factor: 3.969

3.  Pre-clinical screening of immunomodulatory compounds using the parent-into-F1 model.

Authors:  Charles S Via
Journal:  Clin Immunol       Date:  2011-06-12       Impact factor: 3.969

Review 4.  T cells, murine chronic graft-versus-host disease and autoimmunity.

Authors:  Robert A Eisenberg; Charles S Via
Journal:  J Autoimmun       Date:  2012-06-16       Impact factor: 7.094

5.  In vivo maturation of allo-specific CD8 CTL and prevention of lupus-like graft-versus-host disease is critically dependent on T cell signaling through the TNF p75 receptor but not the TNF p55 receptor.

Authors:  Kateryna Soloviova; Maksym Puliaiev; Mark Haas; Charles S Via
Journal:  J Immunol       Date:  2013-03-22       Impact factor: 5.422

6.  Intrinsic Differences in Donor CD4 T Cell IL-2 Production Influence Severity of Parent-into-F1 Murine Lupus by Skewing the Immune Response Either toward Help for B Cells and a Sustained Autoantibody Response or toward Help for CD8 T Cells and a Downregulatory Th1 Response.

Authors:  Kateryna Soloviova; Maksym Puliaiev; Mark Haas; Clifton L Dalgard; Brian C Schaefer; Charles S Via
Journal:  J Immunol       Date:  2015-08-28       Impact factor: 5.422

Review 7.  Biomarkers of peripheral muscle fatigue during exercise.

Authors:  Josef Finsterer
Journal:  BMC Musculoskelet Disord       Date:  2012-11-08       Impact factor: 2.362

Review 8.  Muscle fatigue: general understanding and treatment.

Authors:  Jing-Jing Wan; Zhen Qin; Peng-Yuan Wang; Yang Sun; Xia Liu
Journal:  Exp Mol Med       Date:  2017-10-06       Impact factor: 8.718

9.  A novel monoclonal antibody against human B7-1 protects against chronic graft-vs.-host disease in a murine lupus nephritis model.

Authors:  Lijun Shen; Ying Zhu; Lianhua Han; Yuyu Wang; Tianming Yan; Yong Kong; Shitao Zou; Yuhua Qiu; Yan Xu
Journal:  Exp Ther Med       Date:  2020-08-25       Impact factor: 2.447

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.